Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Change in Cash (2016 - 2025)

InspireMD's Change in Cash history spans 16 years, with the latest figure at -$54.5 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 1858.04% year-over-year to -$54.5 million; the TTM value through Dec 2025 reached -$10.0 million, down 207.56%, while the annual FY2025 figure was -$10.0 million, 207.56% down from the prior year.
  • Change in Cash reached -$54.5 million in Q4 2025 per NSPR's latest filing, down from $51.9 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $51.9 million in Q3 2025 to a low of -$54.5 million in Q4 2025.
  • Average Change in Cash over 5 years is -$185300.0, with a median of -$964500.0 recorded in 2021.
  • Peak YoY movement for Change in Cash: surged 1422.76% in 2021, then tumbled 2502.79% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$1.1 million in 2021, then soared by 166.16% to $698000.0 in 2022, then tumbled by 701.58% to -$4.2 million in 2023, then surged by 173.78% to $3.1 million in 2024, then crashed by 1858.04% to -$54.5 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Change in Cash are -$54.5 million (Q4 2025), $51.9 million (Q3 2025), and -$874000.0 (Q2 2025).